Company profile
Oisin Biotechnologies
Genetic medicines for age-related diseases
- Industry
- Biotechnology Research
- Employees
- 17
- Headquarters
- Seattle, WA
- Founded
- 2014
- LinkedIn followers
- 2,818
- Office locations
- 2
Oisin Biotechnologies company summary
Oisin Biotechnologies is a company in the Biotechnology Research industry, headquartered in Seattle, WA, founded in 2014. On LinkedIn the company has around 17 employees and 2,818 followers. Warmrank detected 15 technologies across 11 categories on oisinbio.com, including Adobe Fonts, Afterpay, Apple iCloud Mail. The company lists 2 office locations. Its listed specialties include longevity therapeutics, genetic medicine, anti-aging, regenerative medicine, gene therapy.
What technology does Oisin Biotechnologies use?
Warmrank detected 15 technologies on oisinbio.com, last checked July 2026. Click any tool to see other companies that use it.
Apple iCloud Mail
Google Workspace
Microsoft 365
Cart Functionality
Squarespace CommerceFont scripts
Adobe Fonts
TypekitCMS
SquarespaceJavaScript frameworks
StimulusJavaScript libraries
Miscellaneous
Open GraphPayment processors
AfterpayPerformance
Priority HintsSecurity
SSL/TLS certificate authorities
Let's EncryptAbout Oisin Biotechnologies
Oisín Biotechnologies is developing a new class of genetic medicines that target the biology of aging. We don't make pills or supplements; we build powerful, redosable genetic therapies and start with indications regulators already understand, so we can attack the mechanisms of age-related decline on a path that leads to approval. Our therapies are built on the Fusogenix Proteo-Lipid Vehicle (PLV), a non-viral delivery technology that fuses directly with target-cell membranes to deliver both DNA and RNA payloads. Delivery has been the Achilles' heel of genetic medicine. Viral approaches can't be safely redosed, carry limited payloads, and struggle to reach tissues beyond the liver. Fusogenix PLV combines the efficiency of viral delivery with the safety and scalability of non-viral systems. Oisín has a growing pipeline that applies one delivery platform across aesthetic and longevity medicine. Targeted fat removal. A precision therapy that selectively eliminates unwanted fat while sparing surrounding tissue — body contouring through a hypodermic needle rather than surgery. Applications span rare disease and the large and growing market for non-invasive fat reduction. Muscle building. Genetic therapies that drive targeted growth and preservation of skeletal muscle. Local applications in aesthetic muscle building establish the foundation for systemic therapies that combat the loss of strength and independence that comes with age. Longevity biology. A deeper pipeline targeting the fundamental drivers of aging including klotho and other longevity-associated factors, extracellular-matrix remodeling, mitochondrial function, cellular reprogramming, and clearance of senescent cells.
Specialties
Where is Oisin Biotechnologies located?
Oisin Biotechnologies lists 2 office locations.
Compare companies similar to Oisin Biotechnologies
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Oisin Biotechnologies oisinbio.com | Biotechnology Research | 17 | 2014 | Seattle, WA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Oisin Biotechnologies
What does Oisin Biotechnologies do?
Oisín Biotechnologies is developing a new class of genetic medicines that target the biology of aging. We don't make pills or supplements; we build powerful, redosable genetic therapies and start with indications regulators already understand, so we can attack the mechanisms of age-related decline on a path that leads to approval. Our therapies are built on the Fusogenix Proteo-Lipid Vehicle (PLV), a non-viral delivery technology that fuses directly with target-cell membranes to deliver both DNA and RNA payloads. Delivery has been the Achilles' heel of genetic medicine. Viral approaches can't be safely redosed, carry limited payloads, and struggle to reach tissues beyond the liver. Fusogenix PLV combines the efficiency of viral delivery with the safety and scalability of non-viral systems. Oisín has a growing pipeline that applies one delivery platform across aesthetic and longevity medicine. Targeted fat removal. A precision therapy that selectively eliminates unwanted fat while sparing surrounding tissue — body contouring through a hypodermic needle rather than surgery. Applications span rare disease and the large and growing market for non-invasive fat reduction. Muscle building. Genetic therapies that drive targeted growth and preservation of skeletal muscle. Local applications in aesthetic muscle building establish the foundation for systemic therapies that combat the loss of strength and independence that comes with age. Longevity biology. A deeper pipeline targeting the fundamental drivers of aging including klotho and other longevity-associated factors, extracellular-matrix remodeling, mitochondrial function, cellular reprogramming, and clearance of senescent cells.
What technology does Oisin Biotechnologies use?
Warmrank detected 15 technologies on oisinbio.com, including Adobe Fonts, Afterpay, Apple iCloud Mail, Cart Functionality, Google Workspace, HSTS, Let's Encrypt, Microsoft 365.
How many employees does Oisin Biotechnologies have?
Oisin Biotechnologies has around 17 employees on LinkedIn.
Where is Oisin Biotechnologies headquartered?
Oisin Biotechnologies is headquartered in Seattle, WA.
Where does Oisin Biotechnologies have offices?
Oisin Biotechnologies lists 2 office locations, including Seattle, WA, US; San Diego, CA, US.
When was Oisin Biotechnologies founded?
Oisin Biotechnologies was founded in 2014.
Build a lead list from companies like Oisin Biotechnologies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.